3-methyl-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-3-ol;7-methyl-2-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]-2,7-diazaspiro[4.4]nonane;2-(3-methylsulfonylazetidin-1-yl)-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]pyridine;[(2R)-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-2-yl]methanol;3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propan-1-amine;1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-ol

C105H115N37O17S7 — CID 160942971

IUPAC3-methyl-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-3-ol;7-methyl-2-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]-2,7-diazaspiro[4.4]nonane;2-(3-methylsulfonylazetidin-1-yl)-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]pyridine;[(2R)-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-2-yl]methanol;3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propan-1-amine;1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-ol
SMILESCC1(O)CN(c2ccc(-c3cccc(S(C)(=O)=O)c3-c3nn[nH]n3)cn2)C1.CN1CCC2(CCN(c3ccc(-c4cccc(S(C)(=O)=O)c4-c4nn[nH]n4)cn3)C2)C1.CS(=O)(=O)c1cccc(-c2ccc(CCCN)nc2)c1-c1nn[nH]n1.CS(=O)(=O)c1cccc(-c2ccc(N3CC(S(C)(=O)=O)C3)nc2)c1-c1nn[nH]n1.CS(=O)(=O)c1cccc(-c2ccc(N3CCC(O)C3)nc2)c1-c1nn[nH]n1.CS(=O)(=O)c1cccc(-c2ccc(N3CC[C@@H]3CO)nc2)c1-c1nn[nH]n1
InChIInChI=1S/C21H25N7O2S.C17H18N6O4S2.3C17H18N6O3S.C16H18N6O2S/c1-27-10-8-21(13-27)9-11-28(14-21)18-7-6-15(12-22-18)16-4-3-5-17(31(2,29)30)19(16)20-23-25-26-24-20;1-28(24,25)12-9-23(10-12)15-7-6-11(8-18-15)13-4-3-5-14(29(2,26)27)16(13)17-19-21-22-20-17;1-17(24)9-23(10-17)14-7-6-11(8-18-14)12-4-3-5-13(27(2,25)26)15(12)16-19-21-22-20-16;1-27(25,26)14-4-2-3-13(16(14)17-19-21-22-20-17)11-5-6-15(18-9-11)23-8-7-12(23)10-24;1-27(25,26)14-4-2-3-13(16(14)17-19-21-22-20-17)11-5-6-15(18-9-11)23-8-7-12(24)10-23;1-25(23,24)14-6-2-5-13(15(14)16-19-21-22-20-16)11-7-8-12(18-10-11)4-3-9-17/h3-7,12H,8-11,13-14H2,1-2H3,(H,23,24,25,26);3-8,12H,9-10H2,1-2H3,(H,19,20,21,22);3-8,24H,9-10H2,1-2H3,(H,19,20,21,22);2*2-6,9,12,24H,7-8,10H2,1H3,(H,19,20,21,22);2,5-8,10H,3-4,9,17H2,1H3,(H,19,20,21,22)/t;;;12-;;/m...1../s1
InChIKeySUTDZPVCLQHPQG-KZEAJKNCSA-N
MW2391.79 g/mol
LogP6.36
Rot. Bonds28

About 3-methyl-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-3-ol;7-methyl-2-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]-2,7-diazaspiro[4.4]nonane;2-(3-methylsulfonylazetidin-1-yl)-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]pyridine;[(2R)-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-2-yl]methanol;3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propan-1-amine;1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-ol

3-methyl-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-3-ol;7-methyl-2-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]-2,7-diazaspiro[4.4]nonane;2-(3-methylsulfonylazetidin-1-yl)-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]pyridine;[(2R)-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-2-yl]methanol;3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propan-1-amine;1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-ol (PubChem CID 160942971) has the molecular formula C105H115N37O17S7 and a molecular weight of 2391.79 g/mol. Its IUPAC name is 3-methyl-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-3-ol;7-methyl-2-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]-2,7-diazaspiro[4.4]nonane;2-(3-methylsulfonylazetidin-1-yl)-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]pyridine;[(2R)-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-2-yl]methanol;3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propan-1-amine;1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-ol.

Molecular Properties

Compound Name3-methyl-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-3-ol;7-methyl-2-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]-2,7-diazaspiro[4.4]nonane;2-(3-methylsulfonylazetidin-1-yl)-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]pyridine;[(2R)-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-2-yl]methanol;3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propan-1-amine;1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-ol
PubChem CID160942971
Molecular FormulaC105H115N37O17S7
Molecular Weight2391.79 g/mol
Exact Mass2389.73
IUPAC Name3-methyl-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-3-ol;7-methyl-2-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]-2,7-diazaspiro[4.4]nonane;2-(3-methylsulfonylazetidin-1-yl)-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]pyridine;[(2R)-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-2-yl]methanol;3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propan-1-amine;1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-ol
SMILESCC1(O)CN(c2ccc(-c3cccc(S(C)(=O)=O)c3-c3nn[nH]n3)cn2)C1.CN1CCC2(CCN(c3ccc(-c4cccc(S(C)(=O)=O)c4-c4nn[nH]n4)cn3)C2)C1.CS(=O)(=O)c1cccc(-c2ccc(CCCN)nc2)c1-c1nn[nH]n1.CS(=O)(=O)c1cccc(-c2ccc(N3CC(S(C)(=O)=O)C3)nc2)c1-c1nn[nH]n1.CS(=O)(=O)c1cccc(-c2ccc(N3CCC(O)C3)nc2)c1-c1nn[nH]n1.CS(=O)(=O)c1cccc(-c2ccc(N3CC[C@@H]3CO)nc2)c1-c1nn[nH]n1
InChIInChI=1S/C21H25N7O2S.C17H18N6O4S2.3C17H18N6O3S.C16H18N6O2S/c1-27-10-8-21(13-27)9-11-28(14-21)18-7-6-15(12-22-18)16-4-3-5-17(31(2,29)30)19(16)20-23-25-26-24-20;1-28(24,25)12-9-23(10-12)15-7-6-11(8-18-15)13-4-3-5-14(29(2,26)27)16(13)17-19-21-22-20-17;1-17(24)9-23(10-17)14-7-6-11(8-18-14)12-4-3-5-13(27(2,25)26)15(12)16-19-21-22-20-16;1-27(25,26)14-4-2-3-13(16(14)17-19-21-22-20-17)11-5-6-15(18-9-11)23-8-7-12(23)10-24;1-27(25,26)14-4-2-3-13(16(14)17-19-21-22-20-17)11-5-6-15(18-9-11)23-8-7-12(24)10-23;1-25(23,24)14-6-2-5-13(15(14)16-19-21-22-20-16)11-7-8-12(18-10-11)4-3-9-17/h3-7,12H,8-11,13-14H2,1-2H3,(H,23,24,25,26);3-8,12H,9-10H2,1-2H3,(H,19,20,21,22);3-8,24H,9-10H2,1-2H3,(H,19,20,21,22);2*2-6,9,12,24H,7-8,10H2,1H3,(H,19,20,21,22);2,5-8,10H,3-4,9,17H2,1H3,(H,19,20,21,22)/t;;;12-;;/m...1../s1
InChIKeySUTDZPVCLQHPQG-KZEAJKNCSA-N
XLogP6.36
TPSA749.23 Ų
H-Bond Donors10
H-Bond Acceptors48
Rotatable Bonds28
Heavy Atoms166
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002391.79
LogP ≤ 56.36
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1048

Analyze 3-methyl-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-3-ol;7-methyl-2-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]-2,7-diazaspiro[4.4]nonane;2-(3-methylsulfonylazetidin-1-yl)-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]pyridine;[(2R)-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-2-yl]methanol;3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propan-1-amine;1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

1-[(1-methylimidazol-2-yl)methyl]-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]phenyl]piperidine;1-[(3-methylimidazol-4-yl)methyl]-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]phenyl]piperidine;(2R)-2-[[4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]phenyl]piperidin-1-yl]methyl]morpholine;2-[1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-3-yl]propan-2-ol;N-[1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-yl]acetamide;[1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-yl]methanol
CID 157485019
1-(azetidin-3-ylmethyl)-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]phenyl]piperidine;1-[(1-methylimidazol-2-yl)methyl]-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]phenyl]piperidine;1-[(3-methylimidazol-4-yl)methyl]-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]phenyl]piperidine;2-[4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]phenyl]piperidin-1-yl]ethanamine;(2R)-2-[[4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]phenyl]piperidin-1-yl]methyl]morpholine;4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]phenyl]-1-(pyrrolidin-3-ylmethyl)piperidine
CID 157730258
1-methyl-4-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrole;N-methyl-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-N-(2-pyrrolidin-1-ylethyl)pyridin-2-amine;2-(3-methylsulfonylazetidin-1-yl)-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]pyridine;3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propan-1-amine;1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-ol;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-[3-(pyrrolidin-1-ylmethyl)azetidin-1-yl]pyridine
CID 159731087
N,N-dimethyl-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-amine;2-[1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-3-yl]propan-2-ol;N-[1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-yl]acetamide;[1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-yl]methanol;2-[1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-yl]propan-2-ol;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-(pyrrolidin-3-ylmethyl)pyridine;N,N,3-trimethyl-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-3-amine
CID 159869947
2-[2-(azetidin-2-yl)ethyl]-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]pyridine;N',N'-dimethyl-N-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-1,3-benzothiazol-2-yl]ethane-1,2-diamine;N,N'-dimethyl-N'-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]ethane-1,2-diamine;3-methyl-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-3-ol;N'-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-1,3-benzothiazol-2-yl]ethane-1,2-diamine;[(2R)-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-2-yl]methanol
CID 160186464
N,N-dimethyl-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-amine;N-methyl-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-N-(2-pyrrolidin-1-ylethyl)pyridin-2-amine;2-[1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-yl]propan-2-ol;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-[3-(pyrrolidin-1-ylmethyl)azetidin-1-yl]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-(pyrrolidin-3-ylmethyl)pyridine;N,N,3-trimethyl-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-3-amine
CID 161681437

Frequently Asked Questions

What is the IUPAC name of 3-methyl-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-3-ol;7-methyl-2-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]-2,7-diazaspiro[4.4]nonane;2-(3-methylsulfonylazetidin-1-yl)-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]pyridine;[(2R)-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-2-yl]methanol;3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propan-1-amine;1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-ol?
The IUPAC name of 3-methyl-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-3-ol;7-methyl-2-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]-2,7-diazaspiro[4.4]nonane;2-(3-methylsulfonylazetidin-1-yl)-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]pyridine;[(2R)-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-2-yl]methanol;3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propan-1-amine;1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-ol (CID 160942971) is 3-methyl-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-3-ol;7-methyl-2-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]-2,7-diazaspiro[4.4]nonane;2-(3-methylsulfonylazetidin-1-yl)-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]pyridine;[(2R)-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-2-yl]methanol;3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propan-1-amine;1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-ol.
What is the SMILES notation for 3-methyl-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-3-ol;7-methyl-2-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]-2,7-diazaspiro[4.4]nonane;2-(3-methylsulfonylazetidin-1-yl)-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]pyridine;[(2R)-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-2-yl]methanol;3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propan-1-amine;1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-ol?
The canonical SMILES for 3-methyl-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-3-ol;7-methyl-2-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]-2,7-diazaspiro[4.4]nonane;2-(3-methylsulfonylazetidin-1-yl)-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]pyridine;[(2R)-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-2-yl]methanol;3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propan-1-amine;1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-ol is CC1(O)CN(c2ccc(-c3cccc(S(C)(=O)=O)c3-c3nn[nH]n3)cn2)C1.CN1CCC2(CCN(c3ccc(-c4cccc(S(C)(=O)=O)c4-c4nn[nH]n4)cn3)C2)C1.CS(=O)(=O)c1cccc(-c2ccc(CCCN)nc2)c1-c1nn[nH]n1.CS(=O)(=O)c1cccc(-c2ccc(N3CC(S(C)(=O)=O)C3)nc2)c1-c1nn[nH]n1.CS(=O)(=O)c1cccc(-c2ccc(N3CCC(O)C3)nc2)c1-c1nn[nH]n1.CS(=O)(=O)c1cccc(-c2ccc(N3CC[C@@H]3CO)nc2)c1-c1nn[nH]n1.
What is the InChIKey of 3-methyl-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-3-ol;7-methyl-2-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]-2,7-diazaspiro[4.4]nonane;2-(3-methylsulfonylazetidin-1-yl)-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]pyridine;[(2R)-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-2-yl]methanol;3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propan-1-amine;1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-ol?
The InChIKey is SUTDZPVCLQHPQG-KZEAJKNCSA-N. The full InChI is InChI=1S/C21H25N7O2S.C17H18N6O4S2.3C17H18N6O3S.C16H18N6O2S/c1-27-10-8-21(13-27)9-11-28(14-21)18-7-6-15(12-22-18)16-4-3-5-17(31(2,29)30)19(16)20-23-25-26-24-20;1-28(24,25)12-9-23(10-12)15-7-6-11(8-18-15)13-4-3-5-14(29(2,26)27)16(13)17-19-21-22-20-17;1-17(24)9-23(10-17)14-7-6-11(8-18-14)12-4-3-5-13(27(2,25)26)15(12)16-19-21-22-20-16;1-27(25,26)14-4-2-3-13(16(14)17-19-21-22-20-17)11-5-6-15(18-9-11)23-8-7-12(23)10-24;1-27(25,26)14-4-2-3-13(16(14)17-19-21-22-20-17)11-5-6-15(18-9-11)23-8-7-12(24)10-23;1-25(23,24)14-6-2-5-13(15(14)16-19-21-22-20-16)11-7-8-12(18-10-11)4-3-9-17/h3-7,12H,8-11,13-14H2,1-2H3,(H,23,24,25,26);3-8,12H,9-10H2,1-2H3,(H,19,20,21,22);3-8,24H,9-10H2,1-2H3,(H,19,20,21,22);2*2-6,9,12,24H,7-8,10H2,1H3,(H,19,20,21,22);2,5-8,10H,3-4,9,17H2,1H3,(H,19,20,21,22)/t;;;12-;;/m...1../s1.
What are the key properties of 3-methyl-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-3-ol;7-methyl-2-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]-2,7-diazaspiro[4.4]nonane;2-(3-methylsulfonylazetidin-1-yl)-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]pyridine;[(2R)-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-2-yl]methanol;3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propan-1-amine;1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-ol?
3-methyl-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-3-ol;7-methyl-2-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]-2,7-diazaspiro[4.4]nonane;2-(3-methylsulfonylazetidin-1-yl)-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]pyridine;[(2R)-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-2-yl]methanol;3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propan-1-amine;1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-ol has a molecular weight of 2391.79 g/mol, XLogP of 6.36, 28 rotatable bonds, 10 hydrogen bond donors, and 48 hydrogen bond acceptors.
Where does this data come from?
All data for 3-methyl-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-3-ol;7-methyl-2-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]-2,7-diazaspiro[4.4]nonane;2-(3-methylsulfonylazetidin-1-yl)-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]pyridine;[(2R)-1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-2-yl]methanol;3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propan-1-amine;1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-ol is sourced from PubChem (CID 160942971), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).